Global Nucleic Acid Drugs Market Growth (Status and Outlook) 2023-2029
According to this study, the global Nucleic Acid Drugs market size will reach US$ million by 2029.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other
Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Nucleic Acid Drugs Key Players
- 4 Nucleic Acid Drugs by Regions
- 5 United States
- 6 Europe
- 7 China
- 8 Rest of World
- 9 Market Drivers, Challenges and Trends
- 10 Key Investors in Nucleic Acid Drugs
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook